CS
CME icon

Cannell & Spears’s CME Group CME Stock Holding History

Cannell & Spears’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$890K Buy
3,014
+319
+12% +$94.8K 0.02% 249
2025
Q4 		$736K Sell
2,695
-90
-3% -$24.5K 0.01% 262
2025
Q3 		$753K Buy
2,785
+598
+27% +$163K 0.01% 258
2025
Q2 		$603K Sell
2,187
-372
-15% -$101K 0.01% 268
2025
Q1 		$679K Sell
2,559
-1,275
-33% -$315K 0.01% 258
2024
Q4 		$890K Sell
3,834
-546
-12% -$126K 0.02% 246
2024
Q3 		$967K Sell
4,380
-9,764
-69% -$2.02M 0.02% 240
2024
Q2 		$2.78M Sell
14,144
-12,332
-47% -$2.55M 0.06% 155
2024
Q1 		$5.7M Buy
26,476
+1,009
+4% +$212K 0.12% 121
2023
Q4 		$5.36M Sell
25,467
-1,846
-7% -$394K 0.43% 35
2023
Q3 		$5.47M Sell
27,313
-5,700
-17% -$1.13M 0.47% 35
2023
Q2 		$6.12M Sell
33,013
-859
-3% -$159K 0.5% 32
2023
Q1 		$6.49M Buy
33,872
+4,595
+16% +$831K 0.58% 31
2022
Q4 		$4.92M Buy
29,277
+5,794
+25% +$1.01M 0.47% 39
2022
Q3 		$4.16M Sell
23,483
-258
-1% -$51K 0.41% 43
2022
Q2 		$4.86M Sell
23,741
-668
-3% -$142K 0.44% 41
2022
Q1 		$5.81M Sell
24,409
-4,934
-17% -$1.16M 0.43% 37
2021
Q4 		$6.7M Sell
29,343
-5,617
-16% -$1.24M 0.45% 36
2021
Q3 		$6.76M Sell
34,960
-75
-0.2% -$15.2K 0.49% 36
2021
Q2 		$7.45M Buy
35,035
+382
+1% +$80.7K 0.54% 32
2021
Q1 		$7.08M Sell
34,653
-415
-1% -$81.7K 0.55% 32
2020
Q4 		$6.38M Buy
35,068
+439
+1% +$74.7K 0.53% 31
2020
Q3 		$5.79M Buy
34,629
+6,520
+23% +$1.1M 0.55% 32
2020
Q2 		$4.57M Sell
28,109
-381
-1% -$68.3K 0.48% 39
2020
Q1 		$4.93M Buy
+28,490
New +$5.67M 0.6% 34

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cannell & Spears's CME Position: Q1 2026 in Review

Cannell & Spears increased its CME Group (CME) stake by 12% in Q1 2026, buying an estimated $94.8K and bringing the position to 3,014 shares worth $890K. The position accounts for 0.02% of the portfolio, ranked #249.

Cannell & Spears first reported a position in CME in Q1 2020 and has held it in 25 quarters since. The position peaked at $7.45M in Q2 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Cannell & Spears held 3,014 shares of CME Group worth $890K as of Q1 2026.
  • Cannell & Spears bought 319 CME Group shares in Q1 2026, an estimated $94.8K.
  • CME Group made up 0.02% of Cannell & Spears's portfolio in Q1 2026, its #249 holding.
  • Cannell & Spears first reported a position in CME Group in Q1 2020 and has held it in 25 quarters since.
  • Cannell & Spears's CME Group position peaked at $7.45M in Q2 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.